For example, the tumor periphery exhibited maintenance of high BV and vascular integrity against monoclonal antibody to VEGF/VEGFR or vessel‐targeting treatment.38, 39, 40 Therefore, preservation of inherent vascular phenotypes against antiangiogenic treatment in the tumor periphery can be regarded as a process in the tumor that potentiates drug resistance. Here, KDR is linked to neoplasm.